Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Celsion (CLSN – Research Report), Vascular Biogenics (VBLT – Research Report) and Portage Biotech Inc (PRTG – Research Report).
Celsion (CLSN)
In a report released today, Emily Bodnar from H.C. Wainwright maintained a Buy rating on Celsion, with a price target of $16.00. The company’s shares closed last Tuesday at $2.09, close to its 52-week low of $1.80.
According to TipRanks.com, Bodnar is a 1-star analyst with an average return of
Celsion has an analyst consensus of Moderate Buy, with a price target consensus of $16.00.
See the top stocks recommended by analysts >>
Vascular Biogenics (VBLT)
In a report released today, Swayampakula Ramakanth from H.C. Wainwright downgraded Vascular Biogenics to Hold. The company’s shares closed last Tuesday at $2.05.
According to TipRanks.com, Ramakanth is a 1-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Vascular Biogenics with a $5.00 average price target, which is a 145.1% upside from current levels. In a report released today, Oppenheimer also downgraded the stock to Hold.
Portage Biotech Inc (PRTG)
H.C. Wainwright analyst Robert Burns reiterated a Buy rating on Portage Biotech Inc today and set a price target of $32.00. The company’s shares closed last Tuesday at $9.38.
According to TipRanks.com, Burns is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Portage Biotech Inc with a $29.00 average price target, a 220.4% upside from current levels. In a report issued on July 15, Oppenheimer also initiated coverage with a Buy rating on the stock with a $26.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on CLSN:
